GLP-1 medications are changing lives — but dermatologists are now flagging a side effect that many women weren't warned about.
You've heard the headlines about GLP-1 drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) helping people lose significant weight. What you may not have heard is what some women are noticing months into treatment: more hair in the shower drain, scalp tenderness, and changes to their nails. Here's what the latest data actually shows — and what you can do about it.
Read More.New research links everyday exposure to phthalates — chemicals found in plastics, fragrances, and personal care products — to reduced ovarian reserve in women.
You might not be able to see them, smell them, or taste them. But phthalates, a family of chemicals used to make plastics flexible and to help fragrances last longer, may be quietly affecting women's reproductive health. A growing body of research, including a study published in the Journal of Clinical Endocrinology and Metabolism, suggests that higher levels of phthalate exposure are linked to lower ovarian reserve — a measure of how many viable eggs a woman has remaining. Here's what the science actually says, and what women can do with that information.
Read More.